| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |